Literature DB >> 32360588

Use of trabecular bone score for risk stratification of patients with monoclonal gammopathy of undetermined significance.

Jad G Sfeir1, Tito D Pena Guzman2, Lucia Bedatsova3, Stephen M Broski4, Matthew T Drake5.   

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a common finding in clinical practice. The risk for developing MGUS increases with aging in parallel with age-associated increases in fracture risk. Although there is good evidence that patients with MGUS suffer from increased fracture risk, no standardized guidelines exist for the evaluation and/or management of skeletal health in patients with MGUS. Trabecular bone score (TBS), a texture index derived from lumbar spine (LS) dual-energy x-ray absorptiometry (DXA) images, provides information about trabecular microarchitecture independent of bone mineral density (BMD). We retrospectively identified 155 adult patients diagnosed with MGUS between 2005 and 2018. This group was matched 1:1 to a control group for sex, age and BMI. TBS was performed retrospectively, and values categorized as low (≤1.23), intermediate (1.23-1.31) or normal (>1.31). Patients had a mean ± SD age of 69.6 ± 10.0. BMD was performed within a median of 28 months (IQR 1-78) of MGUS diagnosis. Cases had a non-statistically significant higher rate of fractures compared to control subjects (27 vs. 17, respectively, p = 0.1). Patients with MGUS had a significantly lower TBS (1.31 ± 0.13 vs. 1.34 ± 0.12, respectively, p < 0.05) and lower LS BMD (1.215 ± 0.223 vs. 1.275 ± 0.247, p < 0.05) compared to controls. Although fractures occurred more commonly in those control subjects with significantly lower TBS values, this was not the case in subjects with MGUS (TBS 1.299 vs. 1.313 in cases with vs. without fractures p = 0.313). Similarly, there was no difference in T-scores in cases with or without fractures (-1.33 vs. -1.37, respectively, p = 0.56). Despite patients with MGUS having a significantly increased fracture risk compared to age-, sex- and BMI-matched control subjects, neither assessment of BMD nor TBS, obtained within two years of MGUS diagnosis, were able to accurately risk stratify MGUS patients. Unlike control subjects, patients with MGUS tend to fracture despite normal BMD and intermediate or normal TBS values, suggesting that deterioration of cortical rather than trabecular skeletal components may be more important for the increased fracture risk seen in MGUS.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; Fracture; Monoclonal gammopathy; Myeloma; Trabecular bone score

Mesh:

Year:  2020        PMID: 32360588      PMCID: PMC7354210          DOI: 10.1016/j.bone.2020.115394

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  30 in total

1.  Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.

Authors:  Ola Landgren; S Vincent Rajkumar; Ruth M Pfeiffer; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Qiuyin Cai; Lynn R Goldin; Neil E Caporaso; Joseph F Fraumeni; William J Blot; Lisa B Signorello
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

2.  Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute osteoporotic vertebral fractures.

Authors:  Terry Golombick; Terry Diamond
Journal:  Acta Haematol       Date:  2008-10-14       Impact factor: 2.195

Review 3.  unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance?

Authors:  Matthew T Drake
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

4.  Prevalence of monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; Janice R Offord; Angela Dispenzieri; Jerry A Katzmann; L Joseph Melton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

5.  Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.

Authors:  R A Kyle
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

6.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

7.  Fracture risk in monoclonal gammopathy of undetermined significance.

Authors:  L Joseph Melton; S Vincent Rajkumar; Sundeep Khosla; Sara J Achenbach; Ann L Oberg; Robert A Kyle
Journal:  J Bone Miner Res       Date:  2004-01       Impact factor: 6.741

8.  Secondary contributors to bone loss in osteoporosis related hip fractures.

Authors:  B J Edwards; C B Langman; A D Bunta; M Vicuna; M Favus
Journal:  Osteoporos Int       Date:  2008-01-08       Impact factor: 4.507

Review 9.  Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.

Authors:  N C Harvey; C C Glüer; N Binkley; E V McCloskey; M-L Brandi; C Cooper; D Kendler; O Lamy; A Laslop; B M Camargos; J-Y Reginster; R Rizzoli; J A Kanis
Journal:  Bone       Date:  2015-05-16       Impact factor: 4.398

Review 10.  Trabecular bone score: a noninvasive analytical method based upon the DXA image.

Authors:  Barbara C Silva; William D Leslie; Heinrich Resch; Olivier Lamy; Olga Lesnyak; Neil Binkley; Eugene V McCloskey; John A Kanis; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.